Ident. | Authors (with country if any) | Title |
---|
003384 (2013) |
Enrico Tombetti [Italie] ; Stefano Franchini [Italie] ; Maurizio Papa [Italie] ; Maria Grazia Sabbadini [Italie] ; Elena Baldissera [Italie] | Treatment of Refractory Takayasu Arteritis with Tocilizumab: 7 Italian Patients from a Single Referral Center |
003385 (2013) |
Cem Gabay [Suisse] ; Paul Emery [Royaume-Uni] ; Ronald Van Vollenhoven [Suède] ; Ara Dikranian [États-Unis] ; Rieke Alten [Allemagne] ; Karel Pavelka [République tchèque] ; Micki Klearman [États-Unis] ; David Musselman [États-Unis] ; Sunil Agarwal [États-Unis] ; Jennifer Green [Royaume-Uni] ; Arthur Kavanaugh [États-Unis] | Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial |
003387 (2013) |
Luigi Muratori [Italie] ; Maria Serena Longhi [Royaume-Uni] | The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies |
003389 (2013) |
Keiko Shimamoto [Japon] ; Tomoki Ito [Japon] ; Yoshio Ozaki [Japon] ; Hideki Amuro [Japon] ; Akihiro Tanaka [Japon] ; Tohru Nishizawa [Japon] ; YONSU SON [Japon] ; Muneo Inaba [Japon] ; Shosaku Nomura [Japon] | Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis |
003393 (2013) |
Mark C. Genovese [États-Unis, Allemagne, Autriche, Canada, Espagne, Royaume-Uni, Suède] ; Andrea Rubbert-Roth ; Josef S. Smolen ; Joel Kremer ; Majed Khraishi ; Juan Gomez-Reino ; Anthony Sebba ; Robert Pilson ; Sarah Williams ; Ronald Van Vollenhoven | Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure |
003394 (2013) |
Jutatip Guptarak [États-Unis] ; Sheshali Wanchoo [États-Unis] ; Julieann Durham-Lee [États-Unis] ; YEWEN WU [États-Unis] ; Dragoslava Zivadinovic [États-Unis] ; Adriana Paulucci-Holthauzen [États-Unis] ; Olivera Nesic [États-Unis] | Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain |
003398 (2013) |
Kei Ikeda [Japon] ; Daiki Nakagomi [Japon] ; Yoshie Sanayama [Japon] ; Mieko Yamagata [Japon] ; Ayako Okubo [Japon] ; Taro Iwamoto [Japon] ; Hirotoshi Kawashima [Japon] ; Kentaro Takahashi [Japon] ; Hiroshi Nakajima [Japon] | Correlation of Radiographic Progression with the Cumulative Activity of Synovitis Estimated by Power Doppler Ultrasound in Rheumatoid Arthritis: Difference Between Patients Treated with Methotrexate and Those Treated with Biological Agents |
003565 (2012) |
Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon] | Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis |
003572 (2012) |
Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon] | Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules |
003575 (2012) |
Monika Schoels [Autriche, États-Unis] ; Daniel Aletaha [Autriche] ; Josef S. Smolen [Autriche] ; John B. Wong [États-Unis] | Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis |
003802 (2012) |
Edouard Pertuiset [France] | Traitement de la polyarthrite rhumatoïde: Les biologiques actuels |
003804 (2012) |
| Tocilizumab (ROACEMRA°) et arthrite juvénile idiopathique systémique :Un recours pour quelques enfants suivis de près |
003805 (2012) |
Daniel Wendling [France] | Thérapeutique des spondylarthrites: A l'ouest, rien de nouveau ? |
003806 (2012) |
Atsushi Ogata [Japon] ; Noriko Umegaki [Japon] ; Ichiro Katayama [Japon] ; Atsushi Kumanogoh [Japon] ; Toshio Tanaka [Japon] | Rhumatisme psoriasique chez deux patients en échec de traitement par le tocilizumab |
003809 (2012) |
Eric Toussirot [France] | Avancées thérapeutiques dans les rhumatismes inflammatoires chroniques: apport des biothérapies |
003810 (2012) |
A. Rkiouak [Maroc] ; K. Ennibi [Maroc] ; A. Zinebi [Maroc] ; Y. Akhouad [Maroc] ; A. Reggad [Maroc] ; M. Rabhi [Maroc] ; J. Chaari [Maroc] | Atteintes articulaires atypiques au cours d'une maladie de Still de l'adulte réfractaire: efficacité des antagonistes de l'interleukine-6 (tocilizumab) |
003811 (2012) |
Carlo Salvarani [Italie] ; Luca Magnani [Italie] ; Mariagrazia Catanoso [Italie] ; Nicolo Pipitone [Italie] ; Annibale Versari [Italie] ; Lucia Dardani [Italie] ; Lia Pulsatelli [Italie] ; Riccardo Meliconi [Italie] ; Luigi Boiardi [Italie] | Tocilizumab: a novel therapy for patients with large-vessel vasculitis |
003812 (2012) |
Charalampos Dragonas [Allemagne] ; Boris Ehrenstein [Allemagne] ; Martin Fleck [Allemagne] | Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection |
003813 (2012) |
S. Unizony [États-Unis] ; L. Arias-Urdaneta [États-Unis] ; E. Miloslavsky [États-Unis] ; S. Arvikar [États-Unis] ; A. Khosroshahi [États-Unis] ; B. Keroack [États-Unis] ; J. R. Stone [États-Unis] ; J. H. Stone [États-Unis] | Tocilizumab for the Treatment of Large-Vessel Vasculitis (Giant Cell Arteritis, Takayasu Arteritis) and Polymyalgia Rheumatica |
003814 (2012) |
Kendra Decelle [États-Unis] ; Evan R. Horton [États-Unis] | Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis |
003815 (2012) |
Christophe Richez [France] ; Thomas Barnetche ; Liliane Khoryati ; Pierre Duffau ; Marie Kostine ; Cécile Contin-Bordes ; Patrick Blanco ; Thierry Schaeverbeke | Tocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage |